For: | Luna J, Zafra J, Areses Manrique MC, Rodríguez A, Sotoca A, Fírvida JL, Chicas-Sett R, Mielgo X, Reyes JCT, Couñago F. New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer. World J Clin Oncol 2021; 12(11): 983-999 [PMID: 34909394 DOI: 10.5306/wjco.v12.i11.983] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v12/i11/983.htm |
Number | Citing Articles |
1 |
Shih-Kai Hung, Moon-Sing Lee, Wen-Yen Chiou, Dai-Wei Liu, Chih-Chia Yu, Liang-Cheng Chen, Ru-Inn Lin, Chia-Hui Chew, Feng-Chun Hsu, Hsuan-Ju Yang, Michael W. Y. Chan, Hon-Yi Lin. Epigenetic modification in radiotherapy and immunotherapy for cancers. Tzu Chi Medical Journal 2024; 36(4): 396 doi: 10.4103/tcmj.tcmj_3_24
|
2 |
Ping Yang, Yingnan Qiao, Mei Meng, Quansheng Zhou. Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.864159
|
3 |
Sarah Cheng, Kuan-Yi Tu, Hsin-Hua Lee. The dynamic duo: A narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review). Oncology Reports 2024; 52(1) doi: 10.3892/or.2024.8755
|
4 |
Kim Melanie Kraus, Caroline Bauer, Benedikt Feuerecker, Julius Clemens Fischer, Kai Joachim Borm, Denise Bernhardt, Stephanie Elisabeth Combs. Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose–Volume–Effect Correlation. Cancers 2022; 14(12): 2948 doi: 10.3390/cancers14122948
|